Back to search

A Randomized Trial of Aspirin to Prevent Colorectal Adenomas

Data up to Jan 2025

Published2003
Citations1,393
References33

Total Citations Per Year

Abstract

References (33)

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

1994 • 3,408 citations

Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients

1994 • 2,993 citations

The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis

2000 • 2,505 citations

Treatment of Colonic and Rectal Adenomas with Sulindac in Familial Adenomatous Polyposis

1993 • 1,739 citations

Colorectal cancer screening: Clinical guidelines and rationale

1997 • 1,546 citations

Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies

1997 • 1,544 citations

A Randomized Trial of Aspirin to Prevent Colorectal Adenomas in Patients with Previous Colorectal Cancer

2003 • 1,124 citations

Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2

2001 • 1,063 citations

Aspirin Use and the Risk for Colorectal Cancer and Adenoma in Male Health Professionals

1994 • 804 citations

Cyclooxygenase-2 Inhibitors in Tumorigenesis (Part I)

1998 • 773 citations

IARC Handbooks of Cancer Prevention

2003 • 751 citations

Sulindac causes regression of rectal polyps in familial adenomatous polyposis

1991 • 736 citations

Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis

2000 • 673 citations

The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut

2002 • 435 citations

Low-Dose Aspirin and Incidence of Colorectal Tumors in a Randomized Trial

1993 • 423 citations

The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut

2002 • 402 citations

Nonsteroidal anti-inflammatory drug gastropathy

2000 • 371 citations

Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate

1999 • 297 citations

Aspirin Use and Colorectal Cancer: Post-Trial Follow-up Data from the Physicians' Health Study

1998 • 292 citations

Prospective blinded trial of the colonoscopic miss-rate of large colorectal polyps

1991 • 283 citations

Lipoxygenase modulation to reverse carcinogenesis.

2001 • 271 citations

Use of Nonsteroidal Anti-inflammatory Drugs and Incidence of Colorectal Cancer

1999 • 265 citations

Epidemiology of Colorectal Adenomas

1994 • 164 citations

Nonsteroidal antiinflammatory drug use and reduced risk of large bowel carcinoma

1998 • 162 citations

Epidemiology of colorectal adenomatous polyps.

1993 • 158 citations

Aspirin as an Adjunct to Screening for Prevention of Sporadic Colorectal Cancer: A Cost-Effectiveness Analysis

2001 • 136 citations

Effect of sulindac on sporadic colonic polyps

1995 • 115 citations

Suppression of Human Colorectal Mucosal Prostaglandins: Determining the Lowest Effective Aspirin Dose

1997 • 115 citations

A dose-finding study of aspirin for chemoprevention utilizing rectal mucosal prostaglandin E(2) levels as a biomarker.

2002 • 55 citations

Eicosanoids and the large intestine☆

2000 • 42 citations

Effect of aspirin on prostaglandin E2 formation and transforming growth factor alpha expression in human rectal mucosa from individuals with a history of adenomatous polyps of the colon.

1999 • 40 citations

Do NSAIDs Prevent Colorectal Cancer?

2000 • 29 citations

The cost-effectiveness of aspirin for chemoprevention of colorectal cancer

2002 • 6 citations

Cited By (0)

No citing papers found in database

A Randomized Trial of Aspirin to Prevent Colorectal Adenomas (2003) – New England Journal of Medicine | Metascience Observatory Explorer